Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | ZF9T5 | — |
Boostrix exposed to -5°F; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 70-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number ZF9T5, expiry date 08-AUG-2026) for prophylaxis. On 09-JUL-2025, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: Boostrix exposed to -5°F). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK receipt date: 10-JUL-2025 A nurse called to report that one dose of the Boostrix vaccine that was exposed to minus 5-degree Fahrenheit because of a temperature excursion was administered to a patient, which led to incorrect storage of drug. Follow-up agreed via email.